Literature DB >> 10404099

Loss of heterozygosity at 10q in tumors of the upper respiratory tract is associated with poor prognosis.

D Gasparotto1, T Vukosavljevic, S Piccinin, L Barzan, S Sulfaro, M Armellin, M Boiocchi, R Maestro.   

Abstract

Frequent loss of a specific chromosomic region in cancers is often associated with inactivation of a tumor-suppressor gene. The long arm of chromosome 10 is deleted in several types of tumor, among them squamous-cell carcinomas of the head and neck (HNSCC). To determine the role of 10q deletions in the tumorigenesis of the upper respiratory tract, 47 HNSCCs were examined for loss of heterozygosity (LOH) at 10q: 43% of the cases analyzed showed LOH at 10q, and 2 distinct hot spots of deletion were identified, at 10q22-23 and 10q25-26. The possible involvement of pTEN/MMAC1, a tumor-suppressor gene mapped at 10q23, was also evaluated. No mutation, homozygous deletion or loss of expression of pTEN/MMAC1 was detected, indicating that inactivation of this gene plays a minor role in HNSCC development. Interestingly, the frequency of deletion at 10q was greater in invasive carcinoma than in adjacent carcinoma in situ, and a significant association between LOH and poor prognosis was observed. Taken together, our results suggest the presence in the long arm of chromosome 10 of (a) tumor-suppressor gene(s) other than pTEN/MMAC1 and presumably involved in the malignant progression of tumors of the upper respiratory tract. Int. J. Cancer (Pred. Oncol.) 84:432-436, 1999. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10404099     DOI: 10.1002/(sici)1097-0215(19990820)84:4<432::aid-ijc18>3.0.co;2-#

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  The determinants of head and neck cancer: Unmasking the PI3K pathway mutations.

Authors:  Fernanda S Giudice; Cristiane H Squarize
Journal:  J Carcinog Mutagen       Date:  2013-08-02

2.  Identification of a candidate tumor suppressor gene RHOBTB1 located at a novel allelic loss region 10q21 in head and neck cancer.

Authors:  Levent B Beder; Mehmet Gunduz; Mamoru Ouchida; Esra Gunduz; Akiko Sakai; Kunihiro Fukushima; Hitoshi Nagatsuka; Sachio Ito; Noriyasu Honjo; Kazunori Nishizaki; Kenji Shimizu
Journal:  J Cancer Res Clin Oncol       Date:  2005-09-17       Impact factor: 4.553

Review 3.  EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy.

Authors:  Christian Freudlsperger; Jeffrey R Burnett; Jay A Friedman; Vishnu R Kannabiran; Zhong Chen; Carter Van Waes
Journal:  Expert Opin Ther Targets       Date:  2010-11-26       Impact factor: 6.902

Review 4.  DNA copy number variation and loss of heterozygosity in relation to recurrence of and survival from head and neck squamous cell carcinoma: a review.

Authors:  Yu Chen; Chu Chen
Journal:  Head Neck       Date:  2008-10       Impact factor: 3.147

5.  Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma.

Authors:  M H Kulke; R D Odze; K S Thakore; G Thomas; H Wang; M Loda; C Eng
Journal:  Br J Cancer       Date:  2001-03-23       Impact factor: 7.640

6.  ADD3 Deletion in Glioblastoma Predicts Disease Status and Survival.

Authors:  Karrie Mei-Yee Kiang; Stella Sun; Gilberto Ka-Kit Leung
Journal:  Front Oncol       Date:  2021-12-14       Impact factor: 6.244

7.  FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation.

Authors:  Emilios Gemenetzidis; Amrita Bose; Adeel M Riaz; Tracy Chaplin; Bryan D Young; Muhammad Ali; David Sugden; Johanna K Thurlow; Sok-Ching Cheong; Soo-Hwang Teo; Hong Wan; Ahmad Waseem; Eric K Parkinson; Farida Fortune; Muy-Teck Teh
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.